Brainsway Deep TMS Therapy - for Brain Disorder Treatment

ADHD in adults - Double-Blind Placebo Control Safety and Feasibility Study

Tel Aviv Medical Center, Israel

1 July, 2011

A clinical trial in attention deficit and hyperactivity disorder (ADHD) patients has begun at the Tel Aviv Medical Center, Israel.

 Attention deficit disorder in adults may be due to hypoactivity of prefrontal areas of the brain. Increasing the activity of these areas may help improve symptoms in many of these patients. In addition there is evidence as to dysfunction in both hemispheres of the brain, but it is difficult to determine the contribution of each hemisphere's pattern of activity to behavioral impairment. 

The purpose of this study is to use high-frequency Brainsway® Deep TMS to stimulate activity either on the left side of the prefrontal cortex (one arm), or on the right side (a second arm), to see if such stimulation improves attention, compared to sham Deep TMS simulation (a third arm).

 45 ADHD patients are expected to participate in the trial.

© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use